The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.126.2.185

Sleep studies and psychiatric examinations were made on three patients with inoperable malignancies whose illnesses were being managed with an experimental low phenylalanine-tyrosine diet. There was a systematic reduction of REM sleep, supporting the findings of Jouvet suggesting that norepinephrine (a metabolic product of phenylalanine and tyrosine) has a role in the maintenance of REM sleep. The patients developed a reversible clinical syndrome manifested by indifference to their environment, lethargy, and impairment of long-term memory.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.